Page last updated: 2024-11-12
guanacastepene
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
guanacastepene: isolated from an unidentified fungus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 10384802 |
SCHEMBL ID | 2034896 |
MeSH ID | M0364044 |
Synonyms (14)
Synonym |
---|
guanacastepene a |
263357-41-1 |
SCHEMBL2034896 |
DTXSID10439100 |
[(2r,3r,3ar,5ar,8s)-9-formyl-8-hydroxy-3a,5a-dimethyl-1-oxo-3-propan-2-yl-3,4,5,6,7,8-hexahydro-2h-benzo[f]azulen-2-yl] acetate |
Q15411011 |
guanacastepene |
(1r,2r,6s,8ar,10ar)-2-(acetyloxy)-1,2,3,6,7,8,8a,9,10,10a-decahydro-6-hydroxy-8a,10a-dimethyl-1-(1-methylethyl)-3-oxobenz[f]azulene-5-carboxaldehyde |
463962-78-9 |
(1r,2r,6s,8ar,10ar)-2-(acetyloxy)-1,2,3,6,7,8,8a,9,10,10a-decahydro-6-hydroxy-8a,10a-dimethyl-1-(1-methylethyl)-3-oxobenz(f)azulene-5-carboxaldehyde |
unii-g5h7zb2hdf |
g5h7zb2hdf , |
guanacastepene a, (+)- |
(+)-guanacastepene |
Research Excerpts
Overview
The guanacastepenes are a family of 15 diterpenes that share a common 5-6-7 tricyclic core, which is decorated with quaternary centers.
Excerpt | Reference | Relevance |
---|---|---|
"The guanacastepenes are a family of 15 diterpenes that share a common 5-6-7 tricyclic core, which is decorated with quaternary centers, unsaturation, hydroxyl and carbonyl groups. " | ( Cyclohexyne cycloinsertion in the divergent synthesis of guanacastepenes. Carreira, EM; Gampe, CM, 2012) | 1.18 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (35)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 29 (82.86) | 29.6817 |
2010's | 6 (17.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (5.71%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 33 (94.29%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |